Quantcast

Latest Aortic valve replacement Stories

2014-10-08 12:28:07

"Recapturable" heart valve tested as alternative to open heart surgery ANN ARBOR, Mich., Oct. 8, 2014 /PRNewswire-USNewswire/ -- The University of Michigan Frankel Cardiovascular Center is one of the first hospitals in the country to implant Medtronic's new investigational device during transcatheter aortic valve replacement (TAVR). The CoreValve(®) Evolut((TM)) R System is being studied in patients with severe aortic stenosis who are considered at high or extreme risk for open...

2014-09-30 23:04:54

Icahn School of Medicine at Mount Sinai research findings show there was no significant difference in 15-year survival or stroke rates in patients aged between 50 and 69 years who had aortic valve replacement with bioprosthetic valves compared with mechanical valves. New York, NY (PRWEB) September 30, 2014 New Icahn School of Medicine at Mount Sinai research findings published in the October 1 issue of JAMA show there was no significant difference in 15-year survival or stroke rates in...

2014-09-23 16:27:38

Data From REPRISE III Clinical Trial Designed to Support U.S. Regulatory Approval MARLBOROUGH, Mass., Sept. 23, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the REPRISE III clinical trial, a pivotal study to evaluate the safety and effectiveness of the Lotus(TM) Valve System in patients with severe aortic stenosis and who are considered to be at either high or extreme risk for surgical valve replacement. The Lotus Valve System is the first transcatheter aortic...

2014-09-13 12:20:33

Transcatheter Valve Durability Sustained Through Five Years WASHINGTON, Sept. 13, 2014 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the presentation of five-year clinical outcomes for inoperable patients treated in The PARTNER Trial, the world's only prospective randomized trial for transcatheter aortic valve replacement (TAVR) in patients deemed too sick for open-heart...

2014-09-09 12:29:07

STASIS Clinical Study Begins in Europe NEWTOWN, Pa., Sept. 9, 2014 /PRNewswire/ -- Micro Interventional Devices, Inc. (MID) reports the first successful clinical case using its Permaseal Cardiac Access and Closure technology. This new technology simplifies minimally invasive aortic valve replacement procedures. The patient is the first to be enrolled in the Secure Transapical Access and Closure Study (STASIS) being conducted in Europe. The first STASIS case was performed by Dr....

2014-08-14 12:27:46

CoreValve® System Now Available to More U.S. Patients than any Other Transcatheter Aortic Valve MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- El Camino Hospital became one of the first hospitals in California to adopt a new minimally invasive system to treat patients with narrowed, failing aortic heart valves who are considered to be at high risk to undergo surgery. The U.S. Food and Drug Administration (FDA) approved the Medtronic CoreValve(®) System to treat patients with...

2014-07-31 17:32:49

Oxford University Press Data taken from the German Aortic Valve Registry and published in the European Journal of Cardio-Thoracic Surgery A survey, published online in the European Journal of Cardio-Thoracic Surgery, of 13,860 patients who had undergone interventions for aortic valve disease in Germany has revealed that over 80% were in the same or a better state of health one year after the intervention, and was satisfied with the procedural outcome. Aortic stenosis – the...

2014-06-17 08:30:12

Veteran Medical Device Executive To Lead Transcatheter Valve Company Through Clinical Trial Phase MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- HLT, Inc., a medical device company developing leading-edge transcatheter aortic valve replacement (TAVR) therapy, today announced the addition of Kevin Bassett as general manager. In his new role, Bassett will lead the development and achievement of HLT's strategic business objectives and milestones in collaboration with parent company,...

2014-04-23 16:31:16

LONDON, April 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons' Confidence and Proficiency to Drive TAVR Procedure...

2014-04-14 23:00:39

A team of Washington University cardiologists and cardiothoracic surgeons recently were first in the region, outside clinical trials, to use the new CoreValve System when performing transcatheter aortic valve replacement (TAVR) procedures. The two patients who received the self-expandable valve, both considered to be at extreme-risk for traditional aortic valve replacement, are recovering at home. St. Louis, MO (PRWEB) April 14, 2014 Specialists at the Washington University and...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related